These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 4358347

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effects of vasoactive drugs on renal vascular resistance in obstructive disease.
    Shenasky JH, Gillenwater JY, Graham SD, Wooster LD.
    J Urol; 1971 Sep; 106(3):355-9. PubMed ID: 4328969
    [No Abstract] [Full Text] [Related]

  • 3. Acute and chronic angiotensin-1 receptor antagonism reverses endothelial dysfunction in atherosclerosis.
    Prasad A, Tupas-Habib T, Schenke WH, Mincemoyer R, Panza JA, Waclawin MA, Ellahham S, Quyyumi AA.
    Circulation; 2000 May 23; 101(20):2349-54. PubMed ID: 10821809
    [Abstract] [Full Text] [Related]

  • 4. Effects of vasoactive agents on intestinal blood flow and motility in the dog.
    Shehadeh Z, Price WE, Jacobson ED.
    Am J Physiol; 1969 Feb 23; 216(2):386-92. PubMed ID: 4304151
    [No Abstract] [Full Text] [Related]

  • 5. Lack of correlation between initial vascular resistance and responses to vasoconstrictor stimuli in the perfused canine hindpaw.
    Greenberg S, Wilson WR.
    Proc Soc Exp Biol Med; 1974 Feb 23; 145(2):546-52. PubMed ID: 4360644
    [No Abstract] [Full Text] [Related]

  • 6. Selective renal vascular effects of ethacrynic acid.
    McNay JL, Kishimoto T.
    J Pharmacol Exp Ther; 1970 Jul 23; 174(1):159-68. PubMed ID: 4316534
    [No Abstract] [Full Text] [Related]

  • 7. Mechanism of action of angiotensin cofactor.
    Berman LB, Roza O, Mitra S, Vertes V.
    Am J Physiol; 1971 May 23; 220(5):1332-6. PubMed ID: 4324943
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Activated oxygen metabolites: do they really play a role in angiotensin II-regulated vascular tone?
    Touyz RM.
    J Hypertens; 2003 Dec 23; 21(12):2235-8. PubMed ID: 14654739
    [No Abstract] [Full Text] [Related]

  • 14. Vascular reactivity in experimental hypertension.
    Laverty R, McGregor DD, McQueen EG.
    N Z Med J; 1968 Mar 23; 67(429):303-9. PubMed ID: 4296989
    [No Abstract] [Full Text] [Related]

  • 15. Role of acetylcholine in the renal vasoconstrictor response to sympathetic nerve stimulation in the dog.
    McGiff JC, Burns RB, Blumenthal MR.
    Circ Res; 1967 Jun 23; 20(6):616-29. PubMed ID: 6057695
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Changes in the resistance and capacity of the cerebral vascular bed under the influence of vasoactive substances].
    Krasil'nikov VG.
    Fiziol Zh SSSR Im I M Sechenova; 1975 Oct 23; 61(10):1531-8. PubMed ID: 1204863
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.